Grant funding: NIA 5R01AG024040 (to I.L.).
Cognition in movement disorders: Where can we hope to be in ten years?
Article first published online: 22 APR 2014
© 2014 International Parkinson and Movement Disorder Society
Special Issue: Cognition and Movement Disorders
Volume 29, Issue 5, pages 704–711, 15 April 2014
How to Cite
Burn, D., Weintraub, D., Ravina, B. and Litvan, I. (2014), Cognition in movement disorders: Where can we hope to be in ten years?. Mov. Disord., 29: 704–711. doi: 10.1002/mds.25850
Relevant conflicts of interest/financial disclosures: Nothing to report.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue published online: 22 APR 2014
- Article first published online: 22 APR 2014
- Manuscript Accepted: 27 JAN 2014
- Manuscript Revised: 10 JAN 2014
- Manuscript Received: 17 DEC 2013
- Parkinson's disease;
- cognitive testing;
Cognitive impairment and dementia associated with movement disorders represent a major management challenge and area of unmet need. This article has focused upon Parkinson's disease as an exemplar condition, but many of the roadblocks and efforts to overcome these are applicable, in a general sense, to other disorders. Short of a “penicillin moment”—a chance discovery or piece of unintended good fortune—progress is likely to be incremental. Cognitive therapies may end up being multiple and possibly multimodal, parallel with the cancer therapy field. Ultimately, benefit for one condition may extend to others as commonality in protein aggregation, synergistic pathological effects between proteins, and pathological spread emerges. © 2014 International Parkinson and Movement Disorder Society